Sulfadoxine-pyrimethamine versus unsupervised artemether-lumefantrine versus unsupervised amodiaquine-artesunate fixed-dose formulation for uncomplicated falciparum malaria in beninese children : a randomized effectiveness now inferiority trial

Le résumé fourni par la source

Raimund helbok1, Eric Kendjo2, Saadou Issifou2, Peter Lackner3, Charles R. Newton4, Maryvonne Kombila5, Tsiri Agbenyega6, Klaus Dietz7, Kalifa Bojang8, Erich Schmutzhard3, Peter G. Kremsner2 1Medical Research Unit, Albert Schweitzer Hospital, Lambarene, Gabon; Innsbruck Medical University, Clinical Department of Neurology, Austria, 2Medical Research Unit, Albert Schweitzer Hospital, Lambarene, Gabon; Department of Parasitology, Institute of Tropical Medicine, University of Tubingen, Tubingen, Germany, 3Innsbruck Medical University, Clinical Department of Neurology, Innsbruck, Austria, 4Centre for Geographical Medicine, Kenya Medical Research Institute Kilifi, Kilifi, Kenya; Neuroscience Unit, Institute of Child Health, University College London, London, United Kingdom, 5Department of Parasitology, Mycology and Tropical Medicine, Faculty of Medicine, University of Health Sciences Libreville, Libreville, Gabon, Gabon, 6University of Science and Technology, School of Medical Science, Kumasi, Ghana, 7Department of Medical Biometry, University of Tubingen, Tubingen, Germany, 8Medical Research Council Laboratories, Banjul, Banjul, Gambia

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.